Combined central retinal artery and vein occlusion is an uncommon vascular pathology that can cause severe and permanent visual impairment. Optical coherence tomography angiography (OCTA) is a newly available, noninvasive imaging technique that can potentially improve understanding of the structural and vascular implications and prognosis of this infrequent pathology. The present report describes the principal clinical findings in a case of combined central retinal artery and vein occlusion, as detected by the different imaging modalities available in a tertiary referral hospital. OCTA wide-field montage images identified an extensive area of nonperfusion on the macula with involvement of the entire retina at nearly 360°. We observed the most severe nonperfusion in the deep capillary plexus, while perfusion of the choriocapillaris was unaffected. Meanwhile, fluorescein angiography (FA) findings revealed a delay in perfusion rate with marked nonperfusion areas in the peripheral retina at 360°. We identified that the wide-field OCTA montage permitted visualization of a similar or wider peripheral retinal Case Díez-Sotelo et al.: OCTA Findings of a Case of Combined CRVO and CRAO 416 area compared with FA. Therefore, OCTA is potentially useful for assessment of the global retinal nonperfusion status at baseline and during follow-up, with the added advantage of being a noninvasive technique.
Introduction
Retinal vein occlusion (RVO) is the second most frequent cause of retinal vascular disease after diabetic retinopathy [1] . Its most severe manifestation is ischemic central RVO (CRVO), which causes visual impairment and a risk of neovascularization. Combined central retinal artery occlusion (CRAO) and CRVO is an uncommon vascular pathology generally associated with systemic disease such as immunological illnesses, malignancies, and coagulopathies [2] .
Fluorescein angiography (FA) has remained the gold standard for visualization of the vascular pathologies of retinal diseases until the advent of optical coherence tomography angiography (OCTA), a novel and noninvasive technique based on OCT technology. OCTA is not a substitute, but rather a complementary technique, to previously available imaging techniques. OCTA enables independent visualization of not only the superficial capillary plexus (SCP), but also the deep capillary plexus (DCP) and the choriocapillaris, allowing a better understanding of retinal vascular injuries and pathologies.
The aim of the present report was to describe and illustrate the principal clinical findings in a patient diagnosed with combined CRVO and CRAO. To our knowledge, this report is the first to directly compare FA and wide-field OCTA montage findings in this uncommon pathology.
Case Report
An 82-year-old man presented with a 2-week history of sudden painless permanent blurred vision in his right eye (OD), without any systemic symptoms such as headache, polymyalgia rheumatic, or jaw claudication that would be indicative of giant cell arteritis. The patient did not report vision loss or other alterations in his left eye (OS). He had a history of arterial hypertension, dyslipidemia, and atrial fibrillation treated with antihypertensive drugs and statins, and was a former smoker. The patient received treatment with acenocoumarol some months prior to the onset of symptoms, but at the time of the first visit, and by his own decision, the patient was not taking this treatment. He reported no surgical or medical ophthalmological history.
The patient underwent a complete ophthalmic examination at baseline and at the 3-and 6-month follow-up visits, including best-corrected visual acuity (BCVA) measurement with the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, intraocular pressure (IOP) measurement, anterior segment examination, funduscopic study, gonioscopy, OCT, and OCTA with a Swept Source OCT Triton (Topcon Corp., Tokyo, Japan) performing 3 × 3 and 6 × 6 mm captures centered on the fovea. Wide-field OCTA montages were also performed with peripheral 6 × 6 and 9 × 9 mm images captured at baseline and at the 3-and 6-month follow-up visits. Adobe Photoshop CC 2018 (Adobe Systems, San Jose, CA, USA) was used to manually create the montages. FA (Spectralis Heidelberg Engineering, Heidelberg, Germany) was also performed at baseline and at the 6-month follow-up visit.
At the first visit, the BCVA was hand motion in the OD and 20/32 in the OS; IOP was 14 and 12 mm Hg, respectively. Slit lamp examination detected a bilateral nuclear cataract.
Funduscopic study revealed hypertensive retinopathy grade 1 and disperse drusen in the OS. The retina of the right eye had a congested appearance with papillary edema, and intraretinal and widespread flame-shaped hemorrhages in all four quadrants, prompting a diagnosis of CRVO. Baseline OCT line HD and macular OCTA findings of 3 × 3 and 6 × 6 mm captures centered on the fovea; initial FA findings are shown and explained in Figure 1 .
Anti-VEGF therapy was the first-line treatment for the patient. He received an initial loading dose of 3-monthly intravitreal injections of aflibercept, followed by a pro re nata regimen over a 6-month period.
At the 3-month funduscopic examination, resorption of the hemorrhages had improved visualization of the vascular structures. Fundus color photography identified more scattered flame-shaped hemorrhages than at baseline, without papillary edema, and extensive emboli on the principal temporal retinal arteries. The latter presented a funduscopic appearance of platelet-fibrin emboli due to their duller white-gray coloration and their stretched arrangement in the arterial lumen. OCT line HD identified more evident inner-layer hyperreflectivity and an important atrophy of inner and outer layers, without retinal edema. Red-free filter photography revealed hyperreflective images corresponding to the emboli on the fundus color photography, confirming the final diagnosis of combined CRVO and CRAO. The absence of whitish coloration of nonperfused retina can be explained by the time of evolution since the diagnosis, until the hemorrhages disappeared, as this sign usually lasts a few weeks. The macular OCT and OCTA findings of the 3-month follow-up visit are shown and described in Figure  2 . The wide-field OCTA montage at the 3-month follow-up visit indicated extensive macular and peripheral nonperfusion areas ( Fig. 2) .
At the 3-month follow-up visit, the BCVA was counting fingers in the OD, which remained unchanged at the 6-month follow-up. In the OS, an IOP of 28 mm Hg at the 3-month examination prompted treatment with a topical prostaglandin analog. The OD with CRVO and CRAO had normal-range IOP. At the 6-month follow-up visit, the patient had not developed rubeosis iridis on the OD, and gonioscopy demonstrated an open angle without signs of angle neovascularization. The funduscopic examination remained similar to that described at the 3-month follow-up visit, without signs of retinal neovascularization. However, some slight differences in the location of the emboli could be observed, which supports the diagnosis of platelet-fibrin emboli causing CRAO. Autofluorescence photography showed hyperautofluorescent images corresponding to emboli observed in the fundus color photography. Macular OCT and OCTA findings, as well as the final FA and wide-field OCTA montages performed at the 6-month follow-up visit, are shown and described in Figure 3 .
Discussion
OCTA is a novel, noninvasive imaging method based on the flow rate of erythrocytes moving above a detection rate threshold through the blood vessel lumen. OCTA uses algorithms to measure the variation in reflected OCT signal amplitude between consecutive cross-sectional B-scans, generating high-quality angiograms of the retina and choroid [3] . SS-OCT Triton was used to obtain OCTA images. This instrument has an A-scan rate of 100,000 scans/s, and uses OCTARA © detection software, which is more sensitive in the detection of low or slow blood flow than other OCTA methods and is the only commercially available SS-OCTA with a 1,050nm light source [4] .
In the past 4 years, OCTA has been used to identify previously unknown pathophysiological features of retinal vascular diseases such as branch RVO (BRVO) [5] [6] [7] , CRVO [5, 7, 8] , and RAO [9, 10] .
Prior findings have suggested that the DCP is most significantly damaged by RVO [5, 11] , necessitating independent evaluation of each plexus. OCTA provides stratigraphic vascular details that have not previously been described with standard FA, which may assist assessments of the extent of retinal nonperfusion areas at baseline and during follow-up. Furthermore, this can provide information than can help predict responses to anti-VEGF treatment and vascular prognosis in vascular diseases. In addition, OCTA technology has the added advantages of being noninvasive and less time-consuming.
Chung and Li [12] reported a case of BRVO and performed a wide-field montage before and after anti-VEGF treatment, which yielded a visualization area of 8 × 8 mm. This is smaller than the area achieved in the second and third montages in our case.
Kaya et al. [13] reported a case of cilio-RAO combined with CRVO, comparing macular OCTA findings with FA images 10 months after treatment with a single intravitreal injection of dexamethasone. In such a chronic phase of the disease, FA showed normal filling of the cilioretinal artery with correct perfusion of the retinal capillary network on the macula. Conversely, OCTA identified nonperfusion areas in both the SCP and DCP, demonstrating its superiority over FA in evaluating the vascular status of the macula in this disease. In our study, we compared FA and OCTA findings not only in the chronic phase but also at baseline. This allowed us to perform suitable imaging of the macula and detect the presence of wide areas of macular ischemia on the SCP and suspected nonperfused areas on the DCP even at the first visit, and to predict the vascular evolution of the disease and its response to treatment. Furthermore, Kaya et al. [13] did not study the peripheral findings on OCTA, as we did.
Wu et al. [14] presented an interesting case of combined CRVO and CRAO that occurred 9 days following cataract surgery with retrobulbar anesthesia, reporting major OCT and OCTA macular findings in this rare pathology for the first time. As reported here, the authors observed the absence of perfusion in both capillary layers on OCTA, with minimal involvement of choriocapillaris. OCT revealed inner-layer hyperreflectivity of the retina and structural alteration of the external layers. Unfortunately, they did not report OCT, OCTA, or FA follow-up findings. Moreover, they did not include peripheral OCTA montages nor did they compare their findings with FA, so no information regarding peripheral perfusion was provided. As described in these prior studies, and confirmed in our report, the choriocapillaris layer appears to be unaffected in combined CRVO and CRAO.
The present study evaluated a case of combined CRVO and CRAO not only with macular OCTA images but also with wide-field OCTA montages to compare the nonperfusion status with FA.
Our patient presented poor fixation at the baseline visit. This enabled us to perform OCTA in the macular and papillary area, but not in the peripheral retina. However, these images provided more information regarding the posterior pole nonperfusion status in the SCP than did FA, due to limited visualization of retinal perfusion with FA caused by the screen effect of the hemorrhages and the contrast leakage. Kashani et al. [15] demonstrated that in OCTA, retinal perfusion can only be assessed in the retinal layers superficial to those involved with intraretinal hemorrhages, as the hemorrhages block the OCTA signal to some extent and cause disruption of the capillary network with no flow signal. Furthermore, intraretinal hemorrhages in CRVO are detected more frequently in DCP than in SCP [15] . Therefore, OCTA allows us to reliably visualize the SCP but not the DCP in the presence of intraretinal hemorrhages. Although neither technique could initially provide us with information about the DCP due to hemorrhages, OCTA gave us at least the same information about macular SCP as FA, with a higher level of capillary resolution, which is difficult to achieve using standard FA.
At the 6-month post-treatment visit, the wide-field OCTA montage permitted visualization of a similar or wider peripheral area than did the FA image. Although OCTA does not provide dynamic information about vascular flow, the present study suggests that it is a useful tool for assessment of the global nonperfusion status of the retina at baseline and during follow-up. Furthermore, OCTA can be performed at every visit and in every patient.
The main limitation of this technique is that it is time-consuming to obtain the wide-field OCTA montage; therefore, the development of automated montage software should be considered because it would be less time-consuming and easier to implement in clinical practice.
To our knowledge, this is the first report to describe the main macular and peripheral OCTA findings of a case of combined CRVO and CRAO, in addition to complete imaging findings at baseline and at the 3-and 6-month follow-up visits, including global perfusion status visualization with SS-OCTA wide-field montages. This report contributes to the understanding of the structural and vascular implications and prognosis of this uncommon disease, without the invasiveness of classic angiography techniques.
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